Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lupski Lab, |
RCV000203264 | SCV000256742 | pathogenic | Benign concentric annular macular dystrophy | 2014-09-25 | criteria provided, single submitter | research | |
Invitae | RCV001208760 | SCV001380166 | pathogenic | Leber congenital amaurosis 7; Cone-rod dystrophy 2 | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser150*) in the CRX gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 150 amino acid(s) of the CRX protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal dominant bull's eye maculopathy (PMID: 25259927). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 218921). For these reasons, this variant has been classified as Pathogenic. |